Skip to main content
Diagnos Inc logo

Diagnos Inc — Investor Relations & Filings

Ticker · ADK ISIN · CA2524423068 LEI · 254900ZF529VWZDVUS82 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 288 across all filing types
Latest filing 2025-03-12 Regulatory Filings
Country CA Canada
Listing TSXV ADK

About Diagnos Inc

https://www.diagnos.com/

Diagnos Inc. is a technology company specializing in software-based services for the healthcare sector, focusing on the early detection of critical health problems. The company leverages its proprietary FLAIRE Artificial Intelligence (AI) platform, which combines contextual imaging and data analysis to develop algorithms, process images, and analyze data. A primary application of this technology is AI retina analysis for screening and monitoring diseases, such as diabetes, to prevent vision loss. Diagnos aims to enable digital transformation in healthcare by providing cost-effective early detection solutions to primary care facilities and specialists across international markets, including North America and Latin America.

Recent filings

Filing Released Lang Actions
News release - French.pdf
Regulatory Filings Classification · 1% confidence The document is a press release (“COMMUNIQUÉ DE PRESSE”) announcing that DIAGNOS has filed a regulatory authorization application with the Saudi Food and Drug Administration for its CARA SYSTEM. It is not a financial report (10-K, IR, ER), not an investor presentation, proxy solicitation, share issue, or any other specific category. It is a standard regulatory announcement/fallback type. Therefore it best fits the “Regulatory Filings” category (RNS).
2025-03-12 French
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing that DIAGNOS Inc. is filing for Saudi FDA authorization of its CARA medical device. It is not an earnings release, management change, dividend notice, or financial report. It falls under general regulatory announcements without fitting into a more specific category, so it is classified as a Regulatory Filing (RNS).
2025-03-12 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a corporate press release announcing amendments to the terms of existing unsecured convertible debentures, including extension of maturity and increase in interest rate. This constitutes a financing activity involving debt instruments and changes to the company’s capital structure. Therefore, it falls under the Capital/Financing Update category (CAP).
2025-02-28 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” under Canadian securities law, signed by the CFO certifying that the interim financial report and MD&A for the period ended December 31, 2024, are accurate. It does not contain the interim financial statements or MD&A themselves (so it is not an Interim/Quarterly Report (IR) nor an MD&A (MDA)), nor is it announcing or presenting the results. Instead, it is a regulatory compliance certificate filing. The best match in the taxonomy for such a regulatory form that does not fit another category is Regulatory Filings (RNS).
2025-02-12 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a certification form (Form 52-109FV2) for interim filings under Canadian securities regulation. It is not the interim financial report itself (IR), nor an announcement of publication. It is a required regulatory form accompanying filings, fitting the general “Regulatory Filings” fallback category.
2025-02-12 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Condensed Consolidated Financial Statements' for DIAGNOS Inc. for the three-month and nine-month periods ended December 31, 2024. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss, Statement of Changes in Equity, Statement of Cash Flows) and detailed explanatory notes. It is not an announcement or a summary, but the full interim report itself, fitting the definition of an Interim/Quarterly Report (IR). 9M 2025
2025-02-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.